RCKT - Rocket Pharma Year-over-year earnings per share growth for the last twelve months
Rocket Pharmaceuticals relies on its own cGMP facility, which guarantees bioreactor stability. The company's innovative viral vectors enable the effective treatment of severe pediatric pathologies. High demand in the rare cardiac disease segment creates a solid foundation for growth. The quarterly EPS growth demonstrates profitability dynamics, where the 3.90 level captures fresh market valuation figures.
rocketpharma.com (RCKT) - metric breakdowns and financial figures
- share price and consensus valuation forecast:
- market capitalization statistics:
- book capitalization data:
- debt obligations and liquidity statistics:
- earnings and valuation multiples indicators:
RCKT - Company Net Income|Future Profit Rocket Pharmaceuticals|RCKT - P/E Multiple|Projected Price to Earnings Rocket Pharmaceuticals Inc|RCKT - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple Rocket Pharma|RCKT - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Rocket Pharmaceuticals|RCKT - Net earnings per share for the last 12 months|Quarterly EPS earnings growth rocketpharma.com|RCKT - Earnings growth in current year|Net earnings per share growth forecast for next year Rocket Pharmaceuticals
- sales revenue and business income indicators:
Basic company analysis:Rocket Pharma - RCKT
Rocket Pharmaceuticals holds a leading position in the development of gene therapies for the treatment of rare blood and heart pathologies. By analyzing the quarterly EPS growth rate, investors assess the dynamics of net profit per share. This metric compares actual results with market expectations to determine the stability of cash flow. While negative values signal risks, in high-tech businesses they often reflect investments in clinical trials. Stable profit growth confirms the long-term commercial viability of innovative drugs.
Competitor analysis
TEM: Quarterly EPS earnings growth|Qiagen Corp - Year-over-year earnings per one share growth for the last 12 months|IONS (Ionis Pharmaceuticals) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months RGEN (Repligen)|Quarterly EPS earnings growth RNA|CRSP (CRISPR Therapeutics) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth WGS (GeneDx Holdings Corp.)|RARE: Year-over-year earnings per share growth for the last 12 months|BEAM - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months sarepta.com|TWST: Quarterly EPS earnings growth|TXG - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Intellia|Earnings per share growth in annualized terms for the last twelve months Stoke Therapeutics STOK|Quarterly EPS earnings growth BLFS|Wave Life Sciences - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth MAZE (Maze Therapeutics, Inc.)|Quarterly EPS earnings growth Sionna Pharma SION|Prime Medicine Bio - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months TSHA (Taysha)|QURE: Quarterly EPS earnings growth|MGTX - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months RGNX|SLDB: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months ocugen.com (OCGN)|Year-over-year net earnings per share change for the last twelve months PacBio Corp|Year-over-year earnings per share growth for the last twelve months Benitec Biopharma BNTC|DSGN: Year-over-year earnings per share growth for the last 12 months|4DMT - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Lexeo Therapeutics, Inc.|Korro Bio (KRRO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months EDIT|SLN (Silence Therapeutics plc) - Quarterly EPS earnings growth|proqr.com (PRQR) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months CDXS (Codexis Bio)|SGMO - Earnings per share growth in annualized terms for the last twelve months|Nautilus Biotechnology, Inc. - Year-over-year net earnings per share growth for the last 12 months|Net earnings per share growth for the trailing year Metagenomi, Inc|Precision BioSciences - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year generationbio.com (GBIO)|Boundless Bio Inc (BOLD) - Year-over-year earnings per share growth for the last twelve months|Exicure Inc. - Year-over-year earnings per one share growth for the last 12 months|IMNN (imunon.com) - Quarterly EPS earnings growth|Phio Pharmaceuticals - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Mustang Bio Corp (MBIO)|Quarterly EPS earnings growth TransCode (RNAZ)|Quarterly EPS earnings growth BNGO (bionanogenomics.com)|APDN (Applied DNA Sciences Inc) - Year-over-year net earnings per share trend for the last twelve months|BLUE - Year-over-year earnings per share growth for the last twelve months|ImmunoPrecise Antibodies Ltd. (IPA) - Year-over-year net earnings per share growth for the last 12 months|OMGA (Omega) - Year-over-year net earnings per share growth for the last 12 months|singulargenomics.com (OMIC) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months RGLS|Syros (SYRS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months telesisbio.com (TBIO)|TCON - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth UBX (Unity Biotechnology Inc.)
